Fig 1.
Flow diagram of children enrolled in the study and information about sides effects.
Table 1.
Demographic data.
Table 2.
PCR results during treatment follow up.
Patients who became negative remained negative. Positive results are for patients who had not became negative before.
Fig 2.
Individuals serological profiles versus time: For ELISA; for IHA, and for F2/3.
Thick red line = smooth regression of the data. Horizontal blue line = cut value.
Fig 3.
Survival curve time to negative serology or PCR.
Table 3.
Median of survival time of antibody anti-T. cruzi.
Fig 4.
Survival curve time to negative serology by age group: For ELISA; for IHA; and for F2/3.